299 related articles for article (PubMed ID: 23172384)
1. Different characteristic phenotypes according to antibody in myasthenia gravis.
Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
J Clin Neuromuscul Dis; 2012 Dec; 14(2):57-65. PubMed ID: 23172384
[TBL] [Abstract][Full Text] [Related]
2. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
[TBL] [Abstract][Full Text] [Related]
3. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis.
Evoli A; Tonali PA; Padua L; Monaco ML; Scuderi F; Batocchi AP; Marino M; Bartoccioni E
Brain; 2003 Oct; 126(Pt 10):2304-11. PubMed ID: 12821509
[TBL] [Abstract][Full Text] [Related]
4. [Ocular involvement in MuSK antibody-positive myasthenia gravis].
Bau V; Hanisch F; Hain B; Zierz S
Klin Monbl Augenheilkd; 2006 Jan; 223(1):81-3. PubMed ID: 16418940
[TBL] [Abstract][Full Text] [Related]
5. Clinical phenotype of muscle-specific tyrosine kinase-antibody-positive myasthenia gravis.
Wolfe GI; Oh SJ
Ann N Y Acad Sci; 2008; 1132():71-5. PubMed ID: 18567855
[TBL] [Abstract][Full Text] [Related]
6. Repetitive nerve stimulation of facial muscles in MuSK antibody-positive myasthenia gravis.
Oh SJ; Hatanaka Y; Hemmi S; Young AM; Scheufele ML; Nations SP; Lu L; Claussen GC; Wolfe GI
Muscle Nerve; 2006 Apr; 33(4):500-4. PubMed ID: 16392120
[TBL] [Abstract][Full Text] [Related]
7. Clinical findings in MuSK-antibody positive myasthenia gravis: a U.S. experience.
Pasnoor M; Wolfe GI; Nations S; Trivedi J; Barohn RJ; Herbelin L; McVey A; Dimachkie M; Kissel J; Walsh R; Amato A; Mozaffar T; Hungs M; Chui L; Goldstein J; Novella S; Burns T; Phillips L; Claussen G; Young A; Bertorini T; Oh S
Muscle Nerve; 2010 Mar; 41(3):370-4. PubMed ID: 19882635
[TBL] [Abstract][Full Text] [Related]
8. Neurophysiological and mitochondrial abnormalities in MuSK antibody seropositive myasthenia gravis compared to other immunological subtypes.
Rostedt Punga A; Ahlqvist K; Bartoccioni E; Scuderi F; Marino M; Suomalainen A; Kalimo H; Stålberg EV
Clin Neurophysiol; 2006 Jul; 117(7):1434-43. PubMed ID: 16737845
[TBL] [Abstract][Full Text] [Related]
9. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
[TBL] [Abstract][Full Text] [Related]
10. Complete stable remission and autoantibody specificity in myasthenia gravis.
Baggi F; Andreetta F; Maggi L; Confalonieri P; Morandi L; Salerno F; Bernasconi P; Montomoli C; Barberis M; Mantegazza R; Antozzi C
Neurology; 2013 Jan; 80(2):188-95. PubMed ID: 23255823
[TBL] [Abstract][Full Text] [Related]
11. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
[TBL] [Abstract][Full Text] [Related]
12. Clinical comparison of muscle-specific tyrosine kinase (MuSK) antibody-positive and -negative myasthenic patients.
Zhou L; McConville J; Chaudhry V; Adams RN; Skolasky RL; Vincent A; Drachman DB
Muscle Nerve; 2004 Jul; 30(1):55-60. PubMed ID: 15221879
[TBL] [Abstract][Full Text] [Related]
13. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies.
Hoch W; McConville J; Helms S; Newsom-Davis J; Melms A; Vincent A
Nat Med; 2001 Mar; 7(3):365-8. PubMed ID: 11231638
[TBL] [Abstract][Full Text] [Related]
14. A comprehensive analysis of the epidemiology and clinical characteristics of anti-LRP4 in myasthenia gravis.
Zisimopoulou P; Evangelakou P; Tzartos J; Lazaridis K; Zouvelou V; Mantegazza R; Antozzi C; Andreetta F; Evoli A; Deymeer F; Saruhan-Direskeneli G; Durmus H; Brenner T; Vaknin A; Berrih-Aknin S; Frenkian Cuvelier M; Stojkovic T; DeBaets M; Losen M; Martinez-Martinez P; Kleopa KA; Zamba-Papanicolaou E; Kyriakides T; Kostera-Pruszczyk A; Szczudlik P; Szyluk B; Lavrnic D; Basta I; Peric S; Tallaksen C; Maniaol A; Tzartos SJ
J Autoimmun; 2014 Aug; 52():139-45. PubMed ID: 24373505
[TBL] [Abstract][Full Text] [Related]
15. Anti-musk antibody after thymectomy in a previously seropositive myasthenic child.
Saulat B; Maertens P; Hamilton WJ; Bassam BA
Neurology; 2007 Aug; 69(8):803-4. PubMed ID: 17709714
[No Abstract] [Full Text] [Related]
16. [Myasthenia gravis with anti-acetylcholine receptor antibody or anti-muscle specific kinase antibody].
Konishi T
Brain Nerve; 2011 Jul; 63(7):695-704. PubMed ID: 21747139
[TBL] [Abstract][Full Text] [Related]
17. Acetylcholine receptors loss and postsynaptic damage in MuSK antibody-positive myasthenia gravis.
Shiraishi H; Motomura M; Yoshimura T; Fukudome T; Fukuda T; Nakao Y; Tsujihata M; Vincent A; Eguchi K
Ann Neurol; 2005 Feb; 57(2):289-93. PubMed ID: 15668981
[TBL] [Abstract][Full Text] [Related]
18. [Seronegative myasthenia and myasthenia gravis with anti-MuSK antibody: a retrospective study of 20 cases].
Aubert S; Salort-Campana E; Franques J; Uzenot D; Pouget J
Rev Neurol (Paris); 2009 Nov; 165(11):901-10. PubMed ID: 19327804
[TBL] [Abstract][Full Text] [Related]
19. Rituximab in the management of refractory myasthenia gravis.
Zebardast N; Patwa HS; Novella SP; Goldstein JM
Muscle Nerve; 2010 Mar; 41(3):375-8. PubMed ID: 19852027
[TBL] [Abstract][Full Text] [Related]
20. Racial differences in myasthenia gravis in Alabama.
Oh SJ; Morgan MB; Lu L; Hatanaka Y; Hemmi S; Young A; Claussen GC
Muscle Nerve; 2009 Mar; 39(3):328-32. PubMed ID: 19127534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
